Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.31 |
| ▸ | ALDH1A3 | P47895 | 3/20 | 0.31 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | CYP2A6 | P11509 | 4/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14740499 | 0.92 | PGR (0.41) | ALDH1A1KDM4EPTGS2RAB9APGR | |
| SCHEMBL1928893 | 0.74 | PDK2 (0.43) | RAB9ATSHRPGRSMN1; SMN2 | |
| SCHEMBL1571002 | 0.74 | PDK2 (0.38) | ALDH1A1KDM4EPGR | |
| SCHEMBL1929731 | 0.74 | TDP2 (0.33) | PGR | |
| SCHEMBL1927377 | 0.74 | AKR1B1 (0.39) | PGR | |
| SCHEMBL28058189 | 0.72 | ALDH1A1 (0.36) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL3361417 | 0.71 | KDM4E (0.31) | ALDH1A1KDM4E | |
| SCHEMBL14427937 | 0.71 | ALK (0.41) | ALDH1A1KDM4EPTGS2RAB9ATSHR | |
| SCHEMBL12982458 | 0.71 | PDK2 (0.38) | ALDH1A1TSHRPGRALDH1A3 | |
| SCHEMBL29588873 | 0.71 | ALDH1A1 (0.41) | ALDH1A1KDM4EPTGS2RAB9ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7439537-B2 | Divinylfluorenes | AGFA GRAPHICS, N.V. (BE) | 2008-10-21 | — | — | US | disclosed |
| EP-1621598-B1 | Divinylfluorenes. | AGFA GRAPHICS NV (BE) | 2008-01-02 | — | — | EP | disclosed |
| US-20060022193-A1 | Divinylfluorenes | AGFA-GEVAERT (BE) | 2006-02-02 | — | — | US | disclosed |
| EP-1621598-A1 | Divinylfluorenes. | Agfa-Gevaert (BE) | 2006-02-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060022193-A1 | Divinylfluorenes | DNER, DLK1, TRPA1 | ALDH1A1 1203/4885KDM4E 3272/4885PTGS2 1321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.